Company Quick10K Filing
FCCC
10-Q 2020-12-31 Filed 2021-02-10
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-13
10-K 2020-03-31 Filed 2020-06-24
10-Q 2019-12-31 Filed 2020-02-13
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-06-27
10-Q 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-13
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-11
10-K 2017-03-31 Filed 2017-06-19
10-Q 2016-12-31 Filed 2017-02-10
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-12
10-K 2016-03-31 Filed 2016-06-17
10-Q 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-06-30
10-Q 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-12-31 Filed 2014-02-07
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-01
10-K 2013-03-31 Filed 2013-06-14
10-Q 2012-12-31 Filed 2013-02-08
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-03
10-K 2012-03-31 Filed 2012-06-12
10-Q 2011-12-31 Filed 2012-02-09
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-07-29
10-K 2011-03-31 Filed 2011-06-13
10-Q 2010-12-31 Filed 2011-02-07
10-Q 2010-09-30 Filed 2010-11-09
10-Q 2010-06-30 Filed 2010-08-06
10-K 2010-03-31 Filed 2010-06-14
10-Q 2009-12-31 Filed 2010-02-12
8-K 2020-09-21

FCCC Financials

FCCC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash167,000,000144,000,000130,000,000117,000111,000,00098,000,00088,000,00079,000,00074,000,00067,000,00050,000,00042,000,00032,000,000368,000,000345,000,000337,000,000326,000,000309,000,000300,000,000293,000,000276,000,000260,000,000250,000,000243,000,000223,000,000205,000,000199,000,000188,000,000149,000,000139,000,000130,000,000120,000,00094,000,00082,000,000
Accounts Receivable
Inventory
PP&E
Assets145,000,000131,000,000118,000112,000,00099,000,00089,000,00080,000,00075,000,00068,000,00051,000,00043,000,00033,000,000372,000,000347,000,000337,000,000333,000,000315,000,000304,000,000295,000,000286,000,000268,000,000255,000,000246,000,000233,000,000214,000,000204,000,000191,000,000162,000,000148,000,000136,000,000123,000,000106,000,00092,000,000
Accounts Payable
Long-Term Debt
Liabilities8,000,0009,000,00010,00013,000,0009,000,0009,000,0009,000,00012,000,00013,000,0009,000,00015,000,00032,000,00010,000,0001,000,0001,000,00010,000,0002,000,0002,000,0003,000,00011,000,0003,000,0002,000,0003,000,0004,000,0002,000,0004,000,00019,000,0006,000,0003,000,0004,000,0008,000,0007,000,0003,000,000
Stockholders' Equity137,000,000122,000,000108,00099,000,00090,000,00080,000,00071,000,00063,000,00055,000,00042,000,00028,000,0001,000,000362,000,000346,000,000336,000,000323,000,000313,000,000302,000,000292,000,000275,000,000265,000,000253,000,000243,000,000229,000,000212,000,000200,000,000172,000,000156,000,000145,000,000132,000,000115,000,00099,000,00089,000,000
Income Statement ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A11,000,00017,000,00014,000,000-41,947,0007,000,0008,000,0008,000,0007,000,0006,000,0006,000,00011,000,0007,000,00027,000,00035,000,00016,000,000-17,000,00013,000,00010,000,00011,000,000-20,000,00017,000,00010,000,00012,000,000-21,000,00014,000,00019,000,00012,000,000-21,000,00016,000,00015,000,00013,000,000-17,000,00016,000,00010,000,000
Tax00000000000000000000000000000
Net Income-13,000,000-18,000,000-15,000,00045,940,000-9,000,000-3,000,000-10,000,000-9,000,000-8,000,000-8,000,000-13,000,000-14,000,000-27,000,000-19,000,000-16,000,000-10,000,000-13,000,000-10,000,000-11,000,000-10,000,000-17,000,000-10,000,000-12,000,000-10,000,000-14,000,000-19,000,000-12,000,000-28,000,000-16,000,000-11,000,000-13,000,000-17,000,000-16,000,000-10,000,000
Cash Flow ($)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-12,000,000-23,000,000-14,000,00048,938,000-6,000,000-13,000,000-10,000,000-9,000,000-5,000,000-7,000,000-17,000,000-8,000,000-10,000,000-44,000,000-23,000,000-8,000,000-11,000,000-17,000,000-9,000,000-7,000,000-17,000,000-16,000,000-10,000,000-7,000,000-20,000,000-18,000,000-6,000,000-11,000,000-39,000,000-10,000,000-10,000,000-26,000,000-12,000,000
Cash Investing0
Cash Financing00000